Cardiome Pharma Corp.
| Article | Date | Source |
|---|
| Cardiome Pharma Corp. to Axe 85 Pct. of Jobs | July 09, 2012 | BioSpace |
| Cardiome Pharma Corp. Falls as Merck & Co., Inc. Ditches Heart Development Pact; Stock Down -1.03(53.37%) @ 1:28PM EDT | March 19, 2012 | BioSpace - Breaking News |
| Cardiome Pharma Corp. Falls as Merck & Co., Inc. Ditches Heart Development Pact; Stock Down -1.02(52.85%) @ 10:25AM EDT | March 19, 2012 | BioSpace - Breaking News |
| Cardiome Pharma Corp. Announces Positive Phase 1 PK/PD Trial Results for Vernakalant Oral | November 04, 2011 | BioSpace - Breaking News |
| Cardiome Pharma Corp. (COM.TO) to Hold Conference Call to Discuss Q1-20 | July 26, 2011 | Biotechnology - Moreover |
| Cardiome Pharma 3Q profit surges on Merck payment | November 11, 2010 | Health News - CNBC |
| Cardiome Pharma Corp. Partner Astellas Pharma Inc. Halts KYNAPID Trial Enrollment After 'Serious' Problem; Stock Falls 13% as of 1:46PM EDT | October 21, 2010 | BioSpace |
| Cardiome Pharma Corp. Partner Astellas Pharma Inc. Halts KYNAPID Trial Enrollment After 'Serious' Problem; Stock Falls 14% as of 10:03AM EDT | October 21, 2010 | BioSpace |
| Research and Markets: Cardiome Pharma Corp.-Detailed Product Pipeline | September 10, 2010 | Pharma News - Business Wire |
| Cardiome Pharma Corp. Gets Nod For Marketing Heart Drug In EU; Receives $30 Million From Merck Sharp & Dohme | September 02, 2010 | BioSpace |
| Cardiome Pharma Corp. Gets Nod For Marketing Heart Drug In EU; Receives $30 Million From Merck & Co., Inc. | September 02, 2010 | BioSpace - Breaking News |
| Cardiome Pharma Corp. Says Heart Drug Program Delayed, Shares Fall | August 11, 2010 | BioSpace |
| Merck & Co., Inc., Cardiome Pharma Corp. Heart Drug Gets Positive EU Review | June 25, 2010 | BioSpace |
| Merck & Co., Inc. And Cardiome Pharma Corp. Say Heart Rhythm Drug Brinavess Worked Better Than Older Therapy In Study | May 14, 2010 | BioSpace |
| Merck & Co., Inc. and Cardiome Pharma Corp. Announce Phase III Study Results Comparing Investigational Compound BRINAVESSTM (Vernakalant) Intravenous to Amiodarone Injection in Conversion of Atrial Fibrillation to Normal Sinus Rhythm | May 14, 2010 | BioSpace - Breaking News |
| Cardiome Pharma Corp. Gets $25 Million Advance from Merck & Co., Inc. | February 17, 2010 | BioSpace |
| Cardiome Pharma Corp. Announces US$25 Million Advance on Line of Credit | February 16, 2010 | Medical Pharma - PR Newswire |
| Cardiome Pharma Corp. Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study | December 18, 2009 | BioSpace - Breaking News |
